Oscar Gluck - Concepedia

Author

Oscar Gluck

University of Arizona

Also Known As

O Gluck, O Glück, O S Gluck, O. Gluck, O.S. Gluck, Oscar Gluck, Oscar S Gluck, Oscar S. Gluck

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Arizona Research Center Vanderbilt University The University of Texas Southwestern Medical Center University of Ottawa

About

Oscar Gluck is an author at University of Arizona specializing in orthopaedics, medicine, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	73
2	Orthopaedics	2	2	97
3	Health Sciences	1	1	30
4	Biostatistics	1	1	43
5	Immunology	1	1	30

Oscar Gluck

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis Peter Tugwell, Theodore Pincus, David E. Yocum, New England Journal of Medicine	1995	535
Evaluation of factors associated with glucocorticoid‐induced osteopenia in patients with rheumatic diseases T R Dykman, Oscar Gluck, William A. Murphy, Arthritis & Rheumatism	1985	282
A double‐blind, randomized, placebo‐controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca Dianne Petrone, John J. Condemi, Rose Fife, Arthritis & Rheumatism	2002	277
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists Laurie Bergstrom, David E. Yocum, Neil M. Ampel, Arthritis & Rheumatism	2004	266
Bone loss in adults receiving alternate day glucocorticoid therapy Oscar Gluck, William A. Murphy, Theodore J. Hahn, Arthritis & Rheumatism	1981	195
Effect of oral 1,25‐dihydroxyvitamin D and calcium on glucocorticoid‐induced osteopenia in patients with rheumatic diseases T R Dykman, Kathleen Haralson, Oscar Gluck, Arthritis & Rheumatism	1984	155
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus Michelle Petri, Philip J. Mease, Joan T. Merrill, Arthritis & Rheumatism	2004	144
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. John Bradley, Alexei Dmitrienko, Alan Kivitz, PubMed	2005	109
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension study C. Michael Stein, Theodore Pincus, David E. Yocum, Arthritis & Rheumatism	1997	93
The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture Mark A. Bach, Kenneth Rockwood, Carl Zetterberg, Journal of the American Geriatrics Society	2004	80

Page 1